Tenet Healthcare (NYSE:THC) Director Cecil Haney Sells 1,300 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) Director Cecil Haney sold 1,300 shares of Tenet Healthcare stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $278.03, for a total value of $361,439.00. Following the completion of the transaction, the director owned 12,553 shares in the company, valued at $3,490,110.59. This trade represents a 9.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Tenet Healthcare Stock Up 0.8%

THC stock opened at $274.06 on Thursday. The stock has a market capitalization of $22.07 billion, a PE ratio of 10.57, a price-to-earnings-growth ratio of 1.04 and a beta of 1.23. Tenet Healthcare Corporation has a one year low of $157.58 and a one year high of $283.05. The company has a fifty day moving average of $226.21 and a 200-day moving average of $208.66. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the business posted $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, analysts expect that Tenet Healthcare Corporation will post 20.98 EPS for the current year.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. UBS Group increased their price target on Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a report on Monday, July 27th. TD Cowen raised their target price on Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a report on Monday, July 27th. Zacks Research upgraded Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Raymond James Financial reiterated an “outperform” rating and set a $285.00 price objective on shares of Tenet Healthcare in a research note on Friday, August 14th. Finally, Mizuho set a $290.00 price target on shares of Tenet Healthcare in a report on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Buy” and an average price target of $273.00.

Institutional Investors Weigh In On Tenet Healthcare

Several large investors have recently made changes to their positions in THC. PeakShares LLC boosted its position in shares of Tenet Healthcare by 3.3% during the 1st quarter. PeakShares LLC now owns 1,693 shares of the company’s stock valued at $319,000 after acquiring an additional 54 shares during the last quarter. Sanctuary Advisors LLC boosted its position in Tenet Healthcare by 0.5% during the first quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock valued at $2,246,000 after buying an additional 57 shares during the period. Quadrant Capital Group LLC increased its holdings in shares of Tenet Healthcare by 0.7% in the fourth quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock worth $1,616,000 after buying an additional 58 shares during the period. Applied Finance Capital Management LLC lifted its stake in shares of Tenet Healthcare by 3.8% in the 1st quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company’s stock valued at $310,000 after acquiring an additional 60 shares during the last quarter. Finally, Syon Capital LLC grew its position in Tenet Healthcare by 5.3% during the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock worth $249,000 after acquiring an additional 63 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.